Search for: "Janssen Research " Results 141 - 160 of 200
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jul 2012, 2:59 am
"We must do more to protect our children from this dangerous chemical and the FDA must continue to aggressively pursue further research and action on BPA to protect the public health. [read post]
25 Jun 2008, 6:34 pm
Researchers estimate that about a third of all nursing home patients have been given antipsychotic drugs. [read post]
21 Apr 2017, 6:25 am
Bulan, Cornerstone Research, on Tuesday, April 18, 2017 Tags: Accounting, Class actions, Derivative suits, Disclosure, Institutional Investors, Market reaction, Rule 10b-5, SEC, SEC enforcement, Section 11, Securities damages, Securities enforcement, Securities litigation, Securities regulation, Settlements Sustainability Matters: Focusing on your Future Today Posted by Elisse B. [read post]
26 Feb 2016, 7:25 am by Brenda Fulmer
There are several depositions underway in New Jersey, Pennsylvania, and Amsterdam involving Bayer and Janssen’s employees. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US:… [read post]
23 Mar 2024, 5:29 pm by CoL .net
Before going into detail as to why Dutch courts maintain this position, Janssen presented [read post]
10 May 2020, 4:28 pm by INFORRM
All  the Courts’ updates on the Coronavirus guidance can be found on the Courts and Tribunal Judiciary Hacked off had a press release “Hacked Off research reveals extent of relentless intrusion on singer Jesy Nelson”. [read post]
29 Aug 2016, 1:19 pm by Michael Grossman
Risperdal is the name Janssen patented and used when marketing the product. [read post]
5 Mar 2018, 4:25 pm by Law Offices of Jeffrey S. Glassman
This variation, researchers say, isn’t explained away by weather, years of exposure, changes in vehicle density or the economy. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Pataday (Olopatadine hydrochloride ophthalmic solution) – US: Patent infringement complaint filed in S D Indiana following a Paragraph IV certification: Alcon Research, Ltd. et al. v. [read post]
11 Jul 2017, 2:30 am by Kluwer UPC News blogger
According to research of IP Kat, and ‘if there are no further delays or unexpected hurdles, (…) it may be that the UK may have ratified the UPC by end of November/early December 2017’. [read post]
5 Mar 2018, 4:25 pm by Law Offices of Jeffrey S. Glassman
This variation, researchers say, isn’t explained away by weather, years of exposure, changes in vehicle density or the economy. [read post]
15 Dec 2010, 2:17 am by Kelly
Becton, Dickinson & Co (Intellectual Property Law Blog) US: Regents of the University of California pursue new patent re-examination in District Court (Patents Post Grant Blog) US: Microsoft v i4i, the burden of proof and the pharma sector (PatLit) US: IRS issues notice to implement annual fee on brand drugs (FDA Law Blog) US: Bright ‘orphan’ ideas blossom (FDA Law Blog) US: Amicus briefs in AMP v USPTO (Patent Docs) (Patent Docs) (Patent Docs) US: University of California files for… [read post]
2 Sep 2015, 8:19 am by Ronald V. Miller, Jr.
  So in the past we have seen drugs rushed on to the market without the internal research necessary to make sure they are safe. [read post]
2 Sep 2015, 8:19 am by Ronald V. Miller, Jr.
  So in the past we have seen drugs rushed on to the market without the internal research necessary to make sure they are safe. [read post]
11 Jul 2017, 2:30 am by Kluwer UPC News blogger
According to research of IP Kat, and ‘if there are no further delays or unexpected hurdles, (…) it may be that the UK may have ratified the UPC by end of November/early December 2017’. [read post]